ANALYST RECOMMENDATIONS : Eli Lilly, Haleon, KB Home, Merck, Pfizer...

Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

• Aston Martin Lagonda: Jefferies remains at Underperform with a price target raised from GBp 120 to GBp 160.
• Avid Technology: Truist Securities initiated coverage with a recommendation of buy. PT set to $45.
• D.R. Horton: J.P. Morgan downgrades to neutral from overweight. PT up 10% to $102.50.
• Eli Lilly: Jefferies initiated coverage with a recommendation of hold. PT down 8.9% to $290.
• Haleon: Jefferies maintains a Hold rating with a price target reduced from 335 to 330 GBp.
• Hilton Grand Vacations: Truist Securities raises PT to $75 from $62. Maintains buy rating.
• InterContinental Hotels: Barclays moves from Overweight to Equal-Weight in line with GBp 6000 target.
• KB Home: J.P. Morgan downgrades to underweight from overweight. PT down 9.1% to $32.50.
• Kingfisher: Jefferies upgrades from hold to buy targeting GBp 330.
• Merck & Co: Jefferies initiated coverage with a recommendation of buy. PT set to $125
• Nichols: HSBC raised its recommendation to buy from hold. PT up 16% to 1,200 pence.
• Pfizer: Jefferies initiated coverage with a recommendation of hold. PT set to $43.
• Rathbones: Jefferies upgrades from Underperform to Hold with a target of GBp 2,000.
• Ryman Hospitality: Truist Securities raised the target to $115 from $104. Maintains buy rating.